Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-21-001693
Filing Date
2021-06-24
Accepted
2021-06-24 20:15:28
Documents
2
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 3943
2 EX-24 DOCUMENT giordano_poa.txt EX-24 3225
  Complete submission text file 0001593968-21-001693.txt   8621
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Giordano Michael F (Reporting) CIK: 0001733915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38997 | Film No.: 211044331